Spotlight on Testing: Test-Guided Management of Treatment Failure to TNF-alpha Antagonists



 

Originally published on December 15, 2014


Lecture Presenter

Julio Delgado, MD, MS

Julio Delgado, MD, MS

Head, Histocompatibility and Immunogenetics Laboratory
ARUP Laboratories
Group Medical Director, Immunology Division
ARUP Laboratories
Co-Executive Director, ARUP Institute for Clinical and Experimental Pathology
ARUP Laboratories
Associate Professor of Pathology
University of Utah School of Medicine

Dr. Delgado is head of the Histocompatibility and Immunogenetics Laboratory, group medical director of the Immunology Division, and co-executive director of the Institute for Clinical and Experimental Pathology at ARUP, as well as an associate professor of pathology at the University of Utah School of Medicine. Dr. Delgado received his MD from Universidad Industrial de Santander in Colombia and his MS degree in epidemiology from the Harvard School of Public Health, completing both his clinical residency training in clinical pathology and his research fellowship in immunology at the Harvard Medical School. He is board certified in clinical pathology and histocompatibility laboratory testing by the American Board of Pathology and the American Board of Histocompatibility and Immunogenetics. His research interests include immunity to infectious diseases and transplantation immunology.


Sponsored by:

University of Utah School of Medicine, Department of Pathology, and ARUP Laboratories